Cargando…

Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Ling, Charlotte, Groop, Leif
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780862/ https://www.ncbi.nlm.nih.gov/pubmed/19940235 http://dx.doi.org/10.2337/db09-1003

Ejemplares similares

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
por: Skyler, Jay S., et al.
Publicado: (2017)

Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link
por: Cheng, Zhiyong, et al.
Publicado: (2014)

Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes
por: Siddiqi, Ferhan S., et al.
Publicado: (2013)

Mitochondrial Stability in Diabetic Retinopathy: Lessons Learned From Epigenetics
por: Kowluru, Renu A.
Publicado: (2019)

The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism
por: Bai, Juli, et al.
Publicado: (2019)

Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus
por: Mannar, Velmurugan, et al.
Publicado: (2023)

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
por: Moon, Hyun-Seuk, et al.
Publicado: (2011)

Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes
por: McCarthy, Mark I., et al.
Publicado: (2008)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
por: Obukhov, Alexander G., et al.
Publicado: (2020)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Air Pollution and Type 2 Diabetes: Mechanistic Insights
por: Rajagopalan, Sanjay, et al.
Publicado: (2012)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
por: Bonner-Weir, Susan, et al.
Publicado: (2008)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus
por: Sapkota, Lokendra Bahadur, et al.
Publicado: (2017)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

The “Perfect Storm” for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity
por: Vaarala, Outi, et al.
Publicado: (2008)

The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)
por: Kelly, Katherine, et al.
Publicado: (2016)

Culture-centered approaches: the relevance of assessing emotional health for Latinos with type 2 diabetes
por: Concha, Jeannie Belinda, et al.
Publicado: (2015)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2008)

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
por: Tuttle, Katherine R., et al.
Publicado: (2021)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
por: Purcell, Anthony W., et al.
Publicado: (2019)

The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial
por: Soare, Andreea, et al.
Publicado: (2015)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vlugihieseghpf2e2v106hspfo